Noncoding RNAs and base modifications: epigenomic players implicated in neurological disorders and tumorigenesis by Li, Yujing et al.
Editorial
Noncoding RNAs and Base Modifications: Epigenomic Players
Implicated in Neurological Disorders and Tumorigenesis
Yujing Li ,1 Changwon Park,1 Hong Jiang ,2 Xuekun Li ,3 and Luciano Vellón4
1Emory University School of Medicine USA, USA
2Xiangya Hospital at the Central South University, China
3Zhejiang University School of Medicine, Hangzhou, Zhejiang 310029, China
4Institute of Biology and Experimental Medicine (IBYME-CONICET), Buenos Aires, Argentina
Correspondence should be addressed to Yujing Li; yli29@emory.edu
Received 9 August 2018; Accepted 9 August 2018; Published 24 September 2018
Copyright © 2018 Yujing Li et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Epigenetics is defined as the study of gene expression
regulations by nongenetic but heritable other than DNA
sequence variations. The epigenetic memories stored in
the base modifications and histone modifications such as
methylation, phosphorylation, and acetylation play impor-
tant roles in regulation of all the metabolic pathways. Any
aberrant alterations could lead to developmental abnor-
malities of diverse diseases including neurological disorders
and cancers.
Before 2009, DNA methylation of 5-cytosine (5-mC) was
the best characterized epigenetic marker. In recent years,
functional significance of 5-hydroxycytosine (5-hmC), the
sixth modified base, as an important epigenetic marker has
been revealed. The 5-hmC, converted from 5mC and cata-
lyzed by the ten-eleven translocation proteins (TETs), has
become a hallmarker of cancer cells. The TET family consists
of three members, TET1, TET2, and TET3, in mammals. It
has been shown that TET1 functions as a tumor suppressor
and tumor promoter in a cancer type-dependent manner.
Deletion and inactivating mutations in the TET2 gene
account for almost 30% of all myeloid malignancies, suggest-
ing the essential roles of 5-hmC and TET2 in tumorigenesis.
In addition, increasing accumulated lines of evidences are
supporting the important roles of 5-hmC in almost all the
known metabolic pathways that are involved in embryogen-
esis, cell reprogramming, stem cell self-renewal, proliferation
and differentiation, central nervous system (CNS) develop-
ment, and aging.
The regulatory mechanisms of 5-hmC in the metabolic
pathways have been acknowledged to serve as the intermedi-
ate in the DNA demethylation process as well as the stable
and independent marker to regulate gene expression by
altering the epigenetic landscapes. Besides the base modifica-
tions, additional complexity of gene expression is added
through dynamic changes on histone proteins and associated
chromatin structural architectures. Although our under-
standing on the functions of epigenetic regulations is still
incomplete, the accumulated data have suggested the link
between aberrant alteration of base modification (such as 5-
mC, 5-hmC, and m6A) levels and neurological diseases,
cardiovascular diseases, and cancers. Additionally, noncod-
ing RNAs (ncRNAs), particularly microRNAs (miRNAs)
small RNAs and long noncoding RNAs (lncRNAs), have also
been characterized as important epigenetic players in various
pathophysiological events. Thus, it is of significance to pub-
lish a special issue focused on this topic. In this special issue,
research and review articles are collected, covering the recent
progress in the roles of the ncRNAS (particularly miRNAs
and lncRNAs) and base modification epigenetic markers in
pathogenesis of neurological disorders and cancers.
With the rapid development of high throughput sequenc-
ing technology and big data analysis, significant attentions
have been paid to the identification of novel miRNA net-
works in regulating gene transcriptions involved in the path-
ogenesis of a certain type of disease such as cancer. Two
research papers deal with the miRNA networks in breast
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cancer and renal cell carcinoma, respectively. Anda-Jauregui
et al. systematically compared the highly influential nonre-
dundant miRNAs named Commodore miRNAs (Cdre-
miRs) from the healthy and cancerous breast tissues and
found the significant variations in the degree, clustering
coefficient, and redundancy distributions for the Cdre-
miRs and their target genes involved in the metabolic net-
works for tumorigenesis. Furthermore, the analysis revealed
five Cdre-miRs, including miR-let7i, miR-292b, miR-511,
and miR-141, and each of which targets the genes involved
in particular functions closely relating to tumorigenesis
and metastasis.
In a separate report, Sage et al. identified a subset of
novel miRNAs in kidney tissues by analyzing small RNA
transcriptomes generated from the clear cell renal cell car-
cinoma (ccRCC) vs. the normal renal tissues. The expres-
sion differences of these novel miRNAs between the
ccRCC and the nonmalignant renal tissues suggest that
they could serve as specific markers of the kidney cancers.
Furthermore, the authors found the significant association
of the newly identified miRNAs with patient survival rates,
providing a new resource for the renal cancer study and
addressing the significance of exploration for the unchar-
acterized epitranscriptomes.
Long noncoding RNAs (lncRNAs) represent another
large class of ncRNAs that regulate gene expression at a tran-
scriptional level by targeting transcriptional activators or
repressors, as well as at posttranscriptional levels by enhanc-
ing pre-mRNA processing, splicing, transport, translation,
and degradation. Functionally, lncRNAs are involved in epi-
genetic modifications as well, leading to chromosome
remodeling. Thus far, only limited numbers of lncRNAs were
identified and characterized. A research paper by Long et al.
reports the identification of a novel lncRNA from the model
mice and detection of the significant difference in expression
between WT and the SCA3/MJD model mice at the tran-
scriptional level, opening a new avenue for dissection of the
SCA3/MJD pathogenesis.
Despite extensive studies on the base modifications, the
majority of the research has focused on the genomic DNA,
limiting the availability of the epitranscriptomic information.
Wei et al. compared 5-mC distribution in the epitranscrip-
tomes of a human and mouse and found that the 5-mC was
highly enriched at 5′UTRs of human and mouse mRNAs,
and an inverse correlation between mRNA and DNA 5-mC
levels at the CpG sites was observed. Generally, it is well
known that 5-mC levels in genomic DNA are negatively cor-
related with transcriptional levels. In contrast, elevated RNA
5-mC levels enhance RNA translation and increase RNA
half-life, although the detailed mechanisms remain elusive.
Additionally, the 5-mC levels of the mitochondrial RNAs
are significantly elevated compared to that of nuclear geno-
mic DNA. Altogether, this study uncovers important roles
of the 5-mC-based epitranscriptomic landscapes in metabo-
lism of RNA particularly mRNA and mitochondrial RNA.
Significant efforts paid to the studies on the epigenetic
involvement to the pathogenesis of tumorigenesis lead to
the dramatic achievements in elucidating the mechanisms,
contributing to development of novel strategies for the
epigenetic-based therapeutic treatments of cancers. Two
separate articles by Feng et al. and He et al. highlighted the
recent progress in epigenetic regulation of cervical cancer
and ovarian cancer, respectively. They focused on the roles
of three base modification markers including 5-mC, 5-
hmC, and 6-mA in DNA and/or RNA in regulation of
genes/pathways involved in tumorigenesis.
To sum up, this special issue specifically addresses the
research progress in base modifications and ncRNA-
mediated epigenetic regulation of cancers and neurological
disorders by either presenting original research outcomes
or highlighting the recent advances in the related research
fields. The authors of the research and review articles in
the special issue hold the hope that they make a shortcut
for the readers to get the related information easily, who
are dedicated enthusiastically in the research field of epige-
netic regulation of tumorigenesis and neurological diseases.
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